ArticleRheumatology (Oxford, England)2023

Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis.

György Kerekes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.